Pierre Massion, MD, Cornelius Vanderbilt Chair and Professor of Medicine, an internationally known expert on early detection and prevention strategies for lung cancer, died April 4 of an apparent heart attack. He was 58. Dr. Massion was director of the Cancer Early Detection and Prevention Initiative and co-leader of the Cancer Health Outcomes and Control […]
A gift in memory of music industry executive and community philanthropist Phran Galante will support the work of Christine Lovly, MD, PhD, associate professor of Medicine and Ingram Professor of Cancer Research, to improve targeted therapies for lung cancer. Galante was a champion for homeless pets, sick children and cancer research in her philanthropic endeavors. […]
After about a decade of treatment for the blood cancer polycythemia vera (PV), Paula Lovell’s bad days started outnumbering the good ones. She told her doctor, Michael Savona, MD, that she was “having one of my spells,” a phrase that her grandmother had used when an occasional sickness wasn’t easily explained. “I had no good […]
Lung cancer and colorectal cancer are the leading causes of cancer deaths in the United States, and even though more Americans now qualify at younger ages for early-detection screenings, many are missing out. The expansion of screening guidelines occurred simultaneously with the ongoing COVID pandemic when people are delaying these potentially life-saving procedures. Cheryl Livingston […]
Their condominium in The Westbury was at the heart of all that William and Frances Blot loved about Nashville, with its proximity to Vanderbilt where he worked for two decades, its sidewalk that led to the greenspaces where they would watch the seasons change, and its residents who became more like friends than neighbors. When […]
When Sonia Richard was diagnosed with stage 3c colorectal cancer at age 30, she felt lost. “I didn’t know anyone my age who had dealt with cancer,” Richard said. The Vanderbilt-Ingram Cancer Center Young Adult Program is a new initiative to help people diagnosed in the prime of their lives. It’s designed for patients ages […]
Brian Rini, MD, Ingram Professor of Cancer Research and chief of Clinical Trials at Vanderbilt-Ingram Cancer Center, is an internationally recognized leader in clinical drug development. Q Why should a cancer patient participate in a clinical trial? A Every drug that is FDA approved today has come through the clinical trials system, so we don’t […]
The darkest hour came for me on Nov. 19, 2018. As I was chit-chatting with the radiology technician and giving advice for her daughter on navigating pre-medical requirements in college, she was taking X-rays of the cancer that I didn’t know was growing inside of me. “Tell her to major in something completely different from […]
As medical science advances upon the molecular drivers of different cancers, and as cancer treatment consequently becomes more targeted and precise, clinical testing for molecular alterations has come online over the past decade to help clinicians match patients to these newer treatments. “We have pills that allow us to target certain genomic alterations in tumors, […]
Vanderbilt-Ingram Cancer Center (VICC) received an overall “exceptional” score for its research impact and excellence in patient care. This achievement merits renewed funding from the National Cancer Institute (NCI) and places it once again in a top group of NCI Comprehensive Cancer Centers. The renewal of the NCI Cancer Center Support Grant (CCSG) provides Vanderbilt-Ingram […]
